RNAC
Cartesian Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.03
+2.16%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-21.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 6, 2026 | Hoge Elizabeth · 10 percent owner | M-Exempt | 22,740 | $0.00 |
| Apr 6, 2026 | Hoge Elizabeth · 10 percent owner | M-Exempt | 758,001 | $0.00 |
| Apr 6, 2026 | Kalayoglu Murat · 10 percent owner | M-Exempt | 758,001 | $0.00 |
| Apr 6, 2026 | Kalayoglu Murat · 10 percent owner | M-Exempt | 22,740 | $0.00 |
| Jan 8, 2026 | Miljkovic Milos · officer: Chief Medical Officer | Sale | 3,573 | $6.82 |
| Jan 8, 2026 | Brunn Carsten · director, officer: President and CEO | Sale | 23,766 | $6.82 |
| Jan 8, 2026 | Davis Blaine · officer: Chief Financial Officer | Sale | 10,591 | $6.82 |
| Jan 6, 2026 | Miljkovic Milos · officer: Chief Medical Officer | A-Award | 27,000 | $0.00 |
| Jan 6, 2026 | ZENNER PATRICK J · director | A-Award | 7,800 | $6.76 |
| Jan 6, 2026 | Seymour June Ann · officer: Chief Accounting Officer | A-Award | 19,000 | $6.76 |
| Jan 6, 2026 | Seymour June Ann · officer: Chief Accounting Officer | A-Award | 6,500 | $0.00 |
| Jan 6, 2026 | Davis Blaine · officer: Chief Financial Officer | A-Award | 37,000 | $0.00 |
| Jan 6, 2026 | Davis Blaine · officer: Chief Financial Officer | A-Award | 109,000 | $6.76 |
| Jan 6, 2026 | BARABE TIMOTHY C · director | A-Award | 2,600 | $0.00 |
| Jan 6, 2026 | BARABE TIMOTHY C · director | A-Award | 7,800 | $6.76 |
| Jan 6, 2026 | English Emily · officer: Chief Operations Officer | A-Award | 24,000 | $0.00 |
| Jan 6, 2026 | English Emily · officer: Chief Operations Officer | A-Award | 71,000 | $6.76 |
| Jan 6, 2026 | Singer Michael · director | A-Award | 2,600 | $0.00 |
| Jan 6, 2026 | Singer Michael · director | A-Award | 7,800 | $6.76 |
| Jan 6, 2026 | SPRINGER TIMOTHY A · director, 10 percent owner: | A-Award | 2,600 | $0.00 |
| Jan 6, 2026 | SPRINGER TIMOTHY A · director, 10 percent owner: | A-Award | 7,800 | $6.76 |
| Jan 6, 2026 | Kalayoglu Murat · director, 10 percent owner: | A-Award | 2,600 | $0.00 |
| Jan 6, 2026 | Kalayoglu Murat · director, 10 percent owner: | A-Award | 7,800 | $6.76 |
| Jan 6, 2026 | ZENNER PATRICK J · director | A-Award | 2,600 | $0.00 |
| Jan 6, 2026 | DeSilva Nishan M · director | A-Award | 7,800 | $6.76 |
| Jan 6, 2026 | Brunn Carsten · director, officer: President and CEO | A-Award | 415,700 | $6.76 |
| Jan 6, 2026 | Brunn Carsten · director, officer: President and CEO | A-Award | 143,200 | $0.00 |
| Jan 6, 2026 | Malik Kemal · director | A-Award | 2,600 | $0.00 |
| Jan 6, 2026 | Malik Kemal · director | A-Award | 7,800 | $6.76 |
| Jan 6, 2026 | Miljkovic Milos · officer: Chief Medical Officer | A-Award | 77,000 | $6.76 |
Institutional positioning
13F filings over the trailing two quarters
New 54Increased 72Reduced 27Sold out 12
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Squarepoint Ops LLC | Increased | 2,254,619 | Aug 14, 2026 |
| SQUAREPOINT OPS LLC | Increased | 2,238,486 | May 15, 2026 |
| BlackRock, Inc. | Increased | 819,239 | Aug 7, 2026 |
| FMR LLC | Reduced | 799,743 | May 15, 2026 |
| 683 Capital Management, LLC | Increased | 650,000 | Aug 14, 2026 |
| BLACKROCK, INC. | Reduced | 599,108 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 555,823 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 407,597 | May 15, 2026 |
| FMR LLC | Reduced | 368,429 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 356,525 | Aug 12, 2026 |
| AQR CAPITAL MANAGEMENT LLC | Increased | 356,456 | Aug 14, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Increased | 330,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 309,887 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 296,293 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 284,317 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 6, 2026